GSK1362
GSK1362 is a selective inverse agonist of REV-ERB. GSK1362disrupts the interaction of REV-ERBα with repressive co-modulators (NCoR1, SMRT2, RIP140). GSK1362 exerts an inverse agonist effect by increasing the transcription of BMAL1 to relieve BMAL1 repression by endogenous REV-ERB ligands. GSK1362 suppresses LPS -induced inflammatory cytokine expression, inhibits IL-1β-induced Cxcl5 transcription in cells. GSK1362 can be used for the study of inflammatory diseases[1].
Product Specifications
CAS Number
2986733-57-5
UNSPSC
12352005
Target
REV-ERB
Related Pathways
Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Field of Research
Inflammation/Immunology
Purity
96.38
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
N#CC1=C(NCCOC)OC(C2=CC=C(N(CC3=CC=C(C=C3)Cl)C)C=C2)=N1
Molecular Formula
C21H21ClN4O2
Molecular Weight
396.87
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Human FGF-19/FGF19 Protein (His Tag)
Recombinant Human FGF-19/FGF19 Protein (His Tag)
PAX5 / BSAP (Early B-Cell Marker) (PCRP-PAX5-1B1), CF488A conjugate, 0.1mg/mL
C1orf100 (NM_001012970) Human Over-expression Lysate
